×
About 8,523 results

ALLMedicine™ Antiphospholipid Syndrome Center

Research & Reviews  4,159 results

Cardiovascular Considerations in Anesthetic Management for a Patient With Antiphospholi...
https://doi.org/10.2344/anpr-67-03-07
Anesthesia Progress; Shibuya M, Kimura Y et. al.

Apr 7th, 2021 - This case report describes the prolonged general anesthetic management of a 41-year-old woman with antiphospholipid syndrome (APS), systemic lupus erythematosus, and previously undiagnosed decreased cardiac function who underwent planned partial r...

Are antiphospholipid antibodies just a common epiphenomenon or are they causative of im...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024929
Clinical Rheumatology; Castillo-Martínez D, Torres Z et. al.

Apr 7th, 2021 - The coronavirus disease 2019 (COVID-19) is the largest public health emergency in recent times. A significant number of patients develop a severe form of COVID-19 characterized by coagulopathy, organ failure, and elevated mortality. In addition, a...

Is the presence of antiphospholipid antibodies a poor prognostic factor for patients wi...
https://doi.org/10.1016/j.ajog.2021.03.039
American Journal of Obstetrics and Gynecology; Pécourt M, Yelnik C et. al.

Apr 4th, 2021 - The characteristics of antiphospholipid syndrome (APS)-associated HELLP syndrome are poorly described, likely due to the low frequency of this combination of syndromes. To compare the characteristics and prognosis of HELLP syndrome in patients wit...

Gastrointestinal symptoms as the first manifestation of antiphospholipid syndrome.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017665
BMC Gastroenterology; Zou X, Fan Z et. al.

Apr 2nd, 2021 - Antiphospholipid syndrome (APS) is an acquired pre-thrombotic autoimmune condition, which produces autoantibodies called antiphospholipid antibodies (APL) against phospholipid-binding plasma proteins. The diagnosis of APS requires at least one of ...

Spinal and cerebral hematoma in systemic lupus erythematosus and antiphospholipid syndr...
https://doi.org/10.1515/dmpt-2020-0163
Drug Metabolism and Personalized Therapy; Duran E, Bilgin E et. al.

Mar 29th, 2021 - Thrombotic events are common in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Warfarin is the most commonly used anticoagulant drug for thrombosis treatment, but it is can interact with many drugs, foods, or medicinal her...

see more →

Guidelines  5 results

European evidence-based recommendations for diagnosis and treatment of paediatric antip...
https://doi.org/10.1136/annrheumdis-2016-211001
Annals of the Rheumatic Diseases; Groot N, de Graeff N et. al.

May 5th, 2017 - Antiphospholipid syndrome (APS) is rare in children, and evidence-based guidelines are sparse. Consequently, management is mostly based on observational studies and physician's experience, and treatment regimens differ widely. The Single Hub and A...

EULAR recommendations for women's health and the management of family planning, assiste...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446003
Annals of the Rheumatic Diseases; Andreoli L, Bertsias GK et. al.

Jul 27th, 2016 - Develop recommendations for women's health issues and family planning in systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS). Systematic review of evidence followed by modified Delphi method to compile questions, elicit exper...

Practice Bulletin No. 132: Antiphospholipid syndrome.
https://doi.org/10.1097/01.AOG.0000423816.39542.0f
Obstetrics and Gynecology;

Nov 21st, 2012 - Antiphospholipid syndrome (APS) is an autoimmune disorder defined by the presence of characteristic clinical features and specified levels of circulating antiphospholipid antibodies (Box 1 and Box 2). Diagnosis requires that at least one clinical ...

Guidelines on the investigation and management of antiphospholipid syndrome.
https://doi.org/10.1111/j.1365-2141.2012.09037.x
British Journal of Haematology; Keeling D, Mackie I et. al.

Feb 8th, 2012 - Guidelines on the investigation and management of antiphospholipid syndrome.|2012|Keeling D,Mackie I,Moore GW,Greer IA,Greaves M,|diagnosis,therapy,

ACOG Practice Bulletin No. 118: antiphospholipid syndrome.
https://doi.org/10.1097/AOG.0b013e31820a61f9
Obstetrics and Gynecology;

Dec 21st, 2010 - ACOG Practice Bulletin No. 118: antiphospholipid syndrome.|2010||

see more →

Clinicaltrials.gov  4,243 results

Cardiovascular Considerations in Anesthetic Management for a Patient With Antiphospholi...
https://doi.org/10.2344/anpr-67-03-07
Anesthesia Progress; Shibuya M, Kimura Y et. al.

Apr 7th, 2021 - This case report describes the prolonged general anesthetic management of a 41-year-old woman with antiphospholipid syndrome (APS), systemic lupus erythematosus, and previously undiagnosed decreased cardiac function who underwent planned partial r...

Are antiphospholipid antibodies just a common epiphenomenon or are they causative of im...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024929
Clinical Rheumatology; Castillo-Martínez D, Torres Z et. al.

Apr 7th, 2021 - The coronavirus disease 2019 (COVID-19) is the largest public health emergency in recent times. A significant number of patients develop a severe form of COVID-19 characterized by coagulopathy, organ failure, and elevated mortality. In addition, a...

Is the presence of antiphospholipid antibodies a poor prognostic factor for patients wi...
https://doi.org/10.1016/j.ajog.2021.03.039
American Journal of Obstetrics and Gynecology; Pécourt M, Yelnik C et. al.

Apr 4th, 2021 - The characteristics of antiphospholipid syndrome (APS)-associated HELLP syndrome are poorly described, likely due to the low frequency of this combination of syndromes. To compare the characteristics and prognosis of HELLP syndrome in patients wit...

Gastrointestinal symptoms as the first manifestation of antiphospholipid syndrome.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017665
BMC Gastroenterology; Zou X, Fan Z et. al.

Apr 2nd, 2021 - Antiphospholipid syndrome (APS) is an acquired pre-thrombotic autoimmune condition, which produces autoantibodies called antiphospholipid antibodies (APL) against phospholipid-binding plasma proteins. The diagnosis of APS requires at least one of ...

Spinal and cerebral hematoma in systemic lupus erythematosus and antiphospholipid syndr...
https://doi.org/10.1515/dmpt-2020-0163
Drug Metabolism and Personalized Therapy; Duran E, Bilgin E et. al.

Mar 29th, 2021 - Thrombotic events are common in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Warfarin is the most commonly used anticoagulant drug for thrombosis treatment, but it is can interact with many drugs, foods, or medicinal her...

see more →

News  111 results

'Hypercoagulation,' Antiphospholipid Antibodies Seen in COVID-19
https://www.staging.medscape.com/viewarticle/928653

Apr 13th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. COVID-19 infection may represent a "hypercoagulable" state, new research suggests. Researchers from China describe three patients admitted to the...

'Hypercoagulation,' Antiphospholipid Antibodies Seen in COVID-19
https://www.medscape.com/viewarticle/928653

Apr 13th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. COVID-19 infection may represent a "hypercoagulable" state, new research suggests. Researchers from China describe three patients admitted to the...

Trending Clinical Topic: Warfarin
https://reference.medscape.com/viewarticle/920469

Oct 31st, 2019 - Each week, we identify one top search term, speculate as to what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, feel free to share them with us on Twitter or Facebook. ...

Rivaroxaban Misfires in Antiphospholipid Syndrome
https://www.medscape.com/viewarticle/920015

Oct 16th, 2019 - Thrombosis is one of the clinical hallmarks of antiphospholipid syndrome (APS), but anticoagulant treatment with rivaroxaban (Xarelto, Janssen Pharmaceuticals) may not be the optimal choice. Findings from a new randomized study failed to show that...

Rivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APS
https://www.mdedge.com/internalmedicine/article/210109/cardiology/rivaroxaban-trends-toward-higher-thrombotic-risk-vitamin?channel=39313
Will Pass

Oct 15th, 2019 - Patients with thrombotic antiphospholipid syndrome (APS) may have a greater risk of recurrent thrombosis when taking rivaroxaban instead of a vitamin K antagonist, suggests a recent trial conducted in Spain. Stroke was also more common among those.

see more →

Patient Education  5 results see all →